Open Pharma

Establishing trust in healthcare information External validation of quality has never been more important for healthcare content creators. As generative AI increasingly powers healthcare queries and browser summaries, and media influencers sprea...

Plain language 🟰 real impact

With AI content everywhere, trust in health info matters more than ever.

Read our latest guest post to explore how accreditation schemes can transform patient resources and strengthen confidence in their quality.

www.openpharma.blog/blog/guest-p...

Weekly digest: AI literacy, open publishing models and equity in OA In this final edition of the weekly digest, we share practical guidance on navigating copyright in medical communications and explore why critical AI literacy is increasingly central to patient empowe...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #AI #PRC #MedicalCommunications #APC #GlobalHealth #FAIRPrinciples

Weekly digest: copyright compliance, AI in publishing and patient experience in clinical trials This week, we highlight how Chiesi expanded copyright compliance and improved content access, understand the role of AI tools in fighting paper mill fraud, and read about STM group’s recommendations f...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #AI #Copyright #PaperMills #SDGs

Weekly digest: Research Integrity Day, patient inclusion and rights retention This week, we look forward to the STM Research Integrity Day and celebrate the launch of Current Medical Research and Opinion’s Putting patients first article collection. We signpost an upcoming webin...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess

Weekly digest: Publication Integrity Week, ORCID funding and Alfasigma OA mandate This week, we look ahead to COPE Publication Integrity Week 2025 and amplify the launch of the 2025 ORCID Global Participation Fund. We also celebrate the launch of Open Pharma Member Alfasigma’s new ...

📢 Read this wseek’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #PublicationEthics @orcid.org @doaj.bsky.social

www.openpharma.blog/blog/news/we...

This quarter: topic meeting about HIFA-WHO report on universal access to healthcare information; Medical Writing article about electronic product information; CC licence landscape project report; Bayer joins Open Pharma as a Supporter; blog post about the PLS Finder project; guest blog post about sharing science on social media; content reuse permissions, restrictions and costs impact assessment survey launch; guest blog post about why open access and plain language matter for students; HIFA OA working group launch; HCP OA survey results presented; roundtable proposals submitted to the ISMPP 2026 European Meeting. Up next : HCP OA perspectives thematic discussion with HIFA; topic meetings about the NISO OA Business Processes and Registered Reports; ISMPP 2026 Annual Meeting session and abstract submissions; PLSP playbook launch; guest blog post by Kora Korzec ; Open Pharma Day and the Open Pharma Annual General Meeting.

Q3 at Open Pharma: a season of progress 🍂

Find out what we've been up to since July in our latest quarterly update www.openpharma.blog/blog/news/q3...

Next up: Open Pharma Day and our AGM. Members and Supporters – get in touch to learn more!

Weekly digest: OA Week, Crossref DOIs and patient involvement in RWD This week, we spotlight the upcoming International Open Access Week 2025, which will focus on the theme of Who owns our knowledge? We signpost the latest Open Pharma guest post by Kora Korzec, which e...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #OpenAccessWeek #OAWeek @crossref.bsky.social #FAIRData @cos.io #PatientPartnership

Scholarly records in Crossref: what publication professionals need to know Metadata of the DOI records registered with Crossref are a cornerstone of scholarly publishing, connecting research outputs through persistent, actionable links. In this post, I clarify what publicati...

🔗 Beyond the link 🔗

In our latest guest post, Kora Korzec breaks down:
🔹 What @crossref.bsky.social is and how it works
🔹 What makes a Crossref DOI actionable
🔹 Why metadata matter

📖 Read the full article here: www.openpharma.blog/blog/guest-p...

Weekly digest: OA and students, transparency in research and HIFA’s survey on OA This week, we share a survey seeking experiences with content reuse permissions, signpost an upcoming global discussion about OA publishing, and highlight an event at Cambridge University discussing i...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #PlainLanguage #ResearchTransparency #Preprints

Why open access and plain language matter for students Traditional publishing practices are stifling global academic potential. Dependency on institutional subscriptions for access to academic literature and prolific use of ‘science speak’ hinders student...

Students 🤝 Open science

Paywalls and science speak are holding students back. But they don’t have to wait for change – they can drive it!

Learn how in our latest opinion article: www.openpharma.blog/blog/guest-p...

Sign up to the Open Pharma newsletter: openpharma.blog/#sign-up-to-our-newsletter

Weekly digest: social media, NISO Plus and OA influence on policy This week, we listen to Amanda Solis and Leslie Rotz as they explain how to harness social media for medical research communication. We share a call for proposals for the 2026 NISO Plus conference and...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess @ismpp.bsky.social @nisoinfo.bsky.social @who.int #ClinicalTrials #MedicalResearch

www.openpharma.blog/blog/news/we...

Weekly digest: a Peer Review Week celebration! This week, we’re reflecting on Peer Review Week, which took place from 15 to 19 September and centred around the theme Rethinking peer review in the AI era. We begin by reading about new approaches to...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #PeerReview #PeerReviewWeek #ResearchIntegrity #MedicalPublishing #ScholarlyPublishing

www.openpharma.blog/blog/news/we...

📢 Calling all medical publications professionals 📢

We need your insights! Share your experiences and help us understand the impact of content reuse permissions, restrictions and costs on the dissemination of medical research:
forms.office.com/e/tRUgRZN9kS

Weekly digest: NISO OABP, effective plain language summaries and PLS for APAC This week, we encourage readers to comment on draft OABP recommendations from NISO and complete a survey exploring how to make PLS clearer and more accessible. We also read guidance on how to make PLS accessible in APAC, and we consider when and how to retract an article. We review insights on transparent peer review based on experiences at the European Journal of Higher Education and ask if pharma is ready to rethink implementation for patient centricity. Finally, we listen to the latest MAPS Elevate podcast, which explores how to improve your journal selection process.

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #PlainLanguageSummaries #APAC #Retractions #PeerReview

Weekly digest: suspicious journals, publication extenders and gold-standard science This week, we read about an AI screening tool developed to identify suspicious publishing practices, review evidence on the effectiveness of publication extenders, and examine concerns around the pote...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #AI #Accessibility #ResearchIntegrity #DataSharing

Science on social media: the double-edged sword of public engagement Social media is a powerful tool for science communication, allowing information to be shared at the speed of a swipe. Researchers, funders and communicators can use platforms such as Bluesky, Instagra...

🧠 Swipe wisely: how to share science responsibly on social media

In her new piece, our intern Ellen explores how researchers, communicators and pharma companies can use social media to build trust in science without falling into the trap of misinformation.

www.openpharma.blog/blog/guest-p...

Bayer becomes a Supporter of Open Pharma Open Pharma and Bayer are proud to announce that Bayer has become the latest Supporter of Open Pharma! Open Pharma aims to drive positive change in the communication of research funded by the pharmace...

🎉 Bayer becomes the newest Supporter of Open Pharma!
Read the full press release on our blog 👉 www.openpharma.blog/blog/news/ba...

#OpenPharma #OpenScience #Welcome #Pharma

Weekly digest: open science knowledge graphs, accessibility and coercive citations This week, we read about the OpenAIRE Graph and the steps we can take to make research and healthcare information more accessible to all. We highlight proposed solutions to improve the peer review pro...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #AI #PeerReview #Plagiarism #OpenAIREGraph #ISMPP

Weekly digest: genAI applications, data sharing and open access This week, we explore how to collaborate effectively while using genAI, how genAI can enhance data sharing practices, and how the NIH is approaching its newly announced top priorities and funding revi...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #genAI #DataSharing #ResearchIntegrity #AI

www.openpharma.blog/blog/news/we...

Weekly digest: article extenders, positive peer reviews and open repositories This week, we explore the impact of article extenders on the readership of PLSPs and CTPs, and we review a critique of Nature’s decision to only publish peer review reports for accepted papers. We als...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #PeerReview #ResearchIntegrity #AI

Weekly digest: rewarding peer review, gaming of science and paying patient authors This week, we read about improving incentives for peer reviewers, the author–editor networks that are used to publish fraudulent research and the gaming of the scientific system through strategic mani...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#PeerReview #ScientificPublishing #PatientAuthors #ResponsibleResearch

Weekly digest: AI-assisted gene set analysis, null results and ORCID integration This week, we learn about NIH’s AI breakthrough in gene set analysis and highlight the importance of null results in the advancement of scientific discovery. We explore ORCID’s role in the evolving re...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #AI #MedicalPublishing #NullResults

www.openpharma.blog/blog/news/we...

Your new ISMPP committee members: Sophie Nobes, Digital Engagement and Visual Communications; Joanna Donnelly, Publication Ethics and Standards

👋 Say hello to your new @ismpp.bsky.social committee members

Weekly digest: the easiness effect, copyright with AI and an AI jury This week, we explore how shortform science videos might be compromising our critical thinking. We read about how copyright regulations are changing with AI, and whether an AI jury could help improve ...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#copyright #AI

www.openpharma.blog/blog/news/we...

The PLS Finder: making plain language summaries more discoverable and accessible for everyone A group of publishers, in collaboration with The Synergist, are working together to create The PLS Finder – a comprehensive aggregator of abstract style plain language summaries (PLS) and standalone p...

🔍 Can’t find PLS and PLSPs on PubMed? You’re not alone.

Plain language content is hard to find, but that’s about to change.

🔗Learn more: www.openpharma.blog/blog/guest-p...

#PlainLanguage #HealthLiteracy #OpenScience #PatientEngagement #PLS #MedicalPublishing #ScienceCommunication #ThePLSFinder

Weekly digest: reimagining ePI, AI-driven safeguards and open science indicators This week, we reimagine ePI to transform the way we access and understand medical information and we read about Frontiers’ use of AI tools to check publication integrity. We also consider the importan...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess

🧠💊 What if product info for medicines wasn’t just a PDF, but a smart, digital platform?

In this article for #MedicalWriting, Open Pharma Co-founder Chris Winchester and co-authors explore how #ePI could transform how we access and understand medical data.

doi.org/10.56012/tcv...

Weekly digest: understanding research integrity, reaching the reader and achieving open access This week, we highlight a new study from STM designed to understand how publishers safeguard publishing integrity and signpost the call for submissions to the 2026 Researcher to Reader Conference. We ...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess

Weekly digest: ditch prompts, improve registries and explore Open Pharma This week, we listen to Conor Grennan as he explains why we should all ditch our trusty AI prompt libraries and just talk to AI like a person instead. We read the latest Open Pharma quarterly update a...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess

Open Pharma quarterly update: April–June 2025 Open Pharma quarterly update: April–June 2025. Read about what we've been up to this quarter!

Q2 2025 was a whirlwind at Open Pharma! 🚀

We launched two research projects, hit the conference circuit and welcomed a new Supporter.

Here’s what we’ve been up to 👇
www.openpharma.blog/blog/news/qu...

#OpenAccess #MedComms #OpenScience